{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:57:51Z","timestamp":1791327471743,"version":"4.3.1"},"reference-count":0,"publisher":"American Society for Clinical Investigation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[1993,4,1]]},"DOI":"10.1172\/jci116331","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T02:41:47Z","timestamp":1204252907000},"page":"1314-1318","source":"Crossref","is-referenced-by-count":274,"title":["Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor."],"prefix":"10.1172","volume":"91","author":[{"given":"D B","family":"Jacoby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G J","family":"Gleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/116331\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:39:43Z","timestamp":1691080783000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/116331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,4,1]]}},"URL":"https:\/\/doi.org\/10.1172\/jci116331","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[1993,4,1]]}}}